News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NeurOp Corporation and Emory University Scientists Target Cognitive and Mental Health Disorders



2/19/2013 9:25:46 AM

ATLANTA--(BUSINESS WIRE)--NeurOp, Inc. has formed a research collaboration with Emory University to study modulation of certain brain cell receptors and its possible impact on several serious cognitive and mental health disorders - schizophrenia, post-traumatic stress disorder (PTSD), and Parkinson’s and Alzheimer’s diseases. NeurOp, a biopharmaceutical company, is working with Emory to accelerate NMDA (N-methyl D-aspartate) receptor research into potential new treatments for these areas of medical need.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES